Plasma Ltbp2 levels predict all-cause mortality, particularly pulmonary death, in patients with acute dyspnoea (including patients with chronic obstructive pulmonary disease and pneumonia acute pulmonary embolism) (Breidthardt et al., 2012). Here, LTBP2 is linked to pneumonia.